Rui-Hong Wang Selected Research

Rui-Hong Wang Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 01/2006
6	Breast Neoplasms (Breast Cancer) 10/2018 - 01/2006
4	Carcinogenesis 10/2011 - 07/2007
3	Genomic Instability 01/2014 - 10/2008
2	Heart Failure 12/2023 - 09/2007
2	Premature Aging 01/2016 - 11/2010
2	Hyperglycemia 01/2013 - 11/2011
2	Insulin Resistance 11/2011 - 11/2010
2	Fatty Liver 11/2010 - 09/2010
2	Iron Overload 09/2007 - 12/2005
1	Ureteral Calculi 09/2021
1	Infections 01/2019
1	Metabolic Diseases (Metabolic Disease) 05/2017
1	Dyslipidemias (Dyslipidemia) 04/2014
1	Glucose Intolerance 01/2013
1	Aneuploidy (Aneuploid) 10/2011
1	Pain (Aches) 03/2011
1	Hypoglycemia (Reactive Hypoglycemia) 11/2010
1	Acrocephalosyndactylia (Apert Syndrome) 09/2007
1	Anemia 09/2007
1	Craniosynostoses (Craniosynostosis) 09/2007
1	Endocrine System Diseases (Endocrine Diseases) 09/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2007
1	Thalassemia 09/2007
1	beta-Thalassemia (Cooley's Anemia) 09/2007
1	Hyperplasia 09/2006

Drug/Important Bio-Agent (IBA)

7	Sirtuin 1IBA 01/2016 - 10/2008
4	Proteins (Proteins, Gene)FDA Link 05/2017 - 09/2007
3	Insulin (Novolin)FDA Link 01/2013 - 11/2010
2	SirtuinsIBA 05/2017 - 10/2011
2	Glucose (Dextrose)FDA LinkGeneric 11/2011 - 11/2010
2	ResveratrolIBA 10/2008 - 10/2008
2	HepcidinsIBA 09/2007 - 12/2005
1	ProcalcitoninIBA 12/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	Doxazosin (Cardura)FDA LinkGeneric 09/2021
1	alfuzosin (UroXatral)FDA Link 09/2021
1	Adrenergic alpha-AntagonistsIBA 09/2021
1	naftopidilIBA 09/2021
1	silodosin FDA Link 09/2021
1	Terazosin (Hytrin)FDA LinkGeneric 09/2021
1	Tamsulosin (Flomax)FDA LinkGeneric 09/2021
1	Tolonium Chloride FDA Link 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 01/2019
1	Cyclin B1IBA 10/2018
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2018
1	Histones (Histone)IBA 01/2016
1	Fibric Acids (Fibrates)IBA 04/2014
1	Glutamine (L-Glutamine)FDA Link 04/2013
1	Mechanistic Target of Rapamycin Complex 2IBA 11/2011
1	AntioxidantsIBA 11/2011
1	Sirtuin 2IBA 10/2011
1	Blood Glucose (Blood Sugar)IBA 11/2010
1	DNA (Deoxyribonucleic Acid)IBA 11/2010
1	Triglycerides (Triacylglycerol)IBA 09/2010
1	Carrier Proteins (Binding Protein)IBA 08/2009
1	SurvivinIBA 10/2008
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2008
1	ChromatinIBA 10/2008
1	AntibodiesIBA 05/2008
1	Transferrin Receptors (Transferrin Receptor)IBA 09/2007
1	U 0126 (UO 126)IBA 09/2007
1	Amino Acids FDA Link 09/2007
1	Erythropoietin FDA Link 09/2007
1	Ferritins (Ferritin)IBA 09/2007
1	GlobinsIBA 09/2007
1	MitogensIBA 09/2007
1	Messenger RNA (mRNA)IBA 09/2007
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2007
1	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 09/2007
1	MAP Kinase Kinase 1IBA 09/2007
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 09/2007
1	beta CateninIBA 07/2007
1	Environmental CarcinogensIBA 07/2007
1	N-amyl-N-methylnitrosamineIBA 07/2007
1	CarcinogensIBA 07/2007
1	Cyclin D1IBA 07/2007
1	Protein Isoforms (Isoforms)IBA 09/2006
1	Insulin-Like PeptidesIBA 07/2006
1	NU 1025IBA 01/2006
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2006
1	1- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA 01/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2005
1	Interleukin-6 (Interleukin 6)IBA 12/2005

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2007
1	Moxibustion 03/2011
1	Blood Transfusion (Blood Transfusions) 09/2007